| Dr Robert Winfield Klink, MD | |
|
7685 Meredith Dr, Gloucester, VA 23061-4151 | |
| (804) 693-4410 | |
| (804) 693-0925 |
| Full Name | Dr Robert Winfield Klink |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology |
| Location | 7685 Meredith Dr, Gloucester, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033116504 | NPI | - | NPPES |
| 6288073 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 0101026446 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert Winfield Klink, MD Po Box 128, Hartfield, VA 23071-0128 Ph: (804) 776-7170 | Dr Robert Winfield Klink, MD 7685 Meredith Dr, Gloucester, VA 23061-4151 Ph: (804) 693-4410 |
News Archive
​Cleveland Clinic, along with the National Cancer Institute, the University of Chicago and Thomas Jefferson University, are the recipients of a $600,000 Special Challenge Award from the Prostate Cancer Foundation (PCF) to investigate the role of abnormally high protein levels in prostate tumors.
Bristol-Myers Squibb Company and Mead Johnson Nutrition Company today announced that Bristol-Myers Squibb Company ("BMS") has amended and extended its offer to exchange up to 170.0 million shares of common stock of Mead Johnson Nutrition Company ("MJN") for outstanding shares of BMS common stock that are validly tendered and not validly withdrawn at an exchange ratio determined by a formula described in a registration statement filed by MJN on Form S-4 (Reg No. 333-163126).
Seeking a way to confirm that patients have taken their medication, University of Florida engineering researchers have added a tiny microchip and digestible antenna to a standard pill capsule. The prototype is intended to pave the way for mass-produced pills that, when ingested, automatically alert doctors, loved ones or scientists working with patients in clinical drug trials.
The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, has launched the first large-scale, multicenter study to investigate the effectiveness of body cooling treatment in infants and children who have had cardiac arrest. The Therapeutic Hypothermia after Pediatric Cardiac Arrest (THAPCA) trials total more than $21 million over six years.
The Washington Post: "The Food and Drug Administration this week began posting online the results of safety evaluations of recently approved drugs and vaccines. The action follows a law enacted in 2007 that requires the agency to provide more safety information to consumers and health professionals. The evaluations must be conducted 18 months after a new drug comes on the market.
› Verified 3 days ago
Dr. Peter C Earl, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7194 Duval Ave, Gloucester, VA 23061 Phone: 423-765-3645 | |
Dr. Elizabeth Rose Lunsford, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7547 Medical Dr, Suite 1200, Gloucester, VA 23061 Phone: 804-693-2670 Fax: 804-693-3704 |